Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-02 · accession 0001819790-23-000085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-05 | 2023-12-02 | TARS | YARNO WENDY L | Dir | M - OptEx | — | +5,000 | 7,000 | +250% | — |
| D | 2023-12-05 | 2023-12-02 | TARS | YARNO WENDY L | Dir | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-02 | M | A | 5,000 | — | 7,000 | D | — | — | (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. |
| 2 | Derivative | Restricted Stock Units | 2023-12-02 | M | D | 5,000 | $0.00 | 0 | D | — · — to — | 5,000 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Company's common stock. (F3) RSUs granted in connection with the Reporting Person's service as the Lead Independent Director. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. |